JEAN CHRISTOPHE
SEC CIK 1378435 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Dir | 11.7K | — | — | 3 | 2024-06-21 | 2026-06-23 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
| 11 | JEAN CHRISTOPHE | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 18:09 | 2026-06-23 | RYTM | RHYTHM PHARMACEUTICALS, INC. | JEAN CHRISTOPHE | Dir | M - OptEx | — | +4,712 | 11.7K | +67% | — |
| D | 2025-06-23 | 2025-06-18 | RYTM | RHYTHM PHARMACEUTICALS, INC. | JEAN CHRISTOPHE | Dir | M - OptEx | — | +4,000 | 7,000 | +133% | — |
| D | 2024-06-25 | 2024-06-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | JEAN CHRISTOPHE | Dir | M - OptEx | — | +3,000 | 3,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations